Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Big Pharma's a C student, rep study finds, with Bayer at the top, Novartis at bottom
Fierce Pharma
Fri, 05/15/15 - 09:30 am
Tags:
Big Pharma, Novartis, Bayer
GSK's Curious Oncology Research Position -- A Recipe For Failure?
Forbes
Tue, 05/12/15 - 10:17 am
Tags:
GSK, R&D, oncology, Novartis
Drug Makers are Having Trouble Improving Their Reputations: Survey
WSJ Pharmalot
Tue, 05/12/15 - 09:28 am
Tags:
pharma industry, Bayer, Novartis
Novartis grabs Zykadia approval in Europe, setting the stage for PD-L1 showdown
Fierce Pharma
Fri, 05/8/15 - 04:38 pm
Tags:
Novartis, Zykadia, Europe, Pfizer, Xalkori, PDL-1 inhibitors
Novartis AG's 'biosimilar' drug sale blocked by U.S. appeals court
Yahoo/Reuters
Thu, 05/7/15 - 09:38 pm
Tags:
Novartis, biosimilars, Neupogen, Amgen
Big Pharma's cardiovascular sales ain't what they used to be
Fierce Pharma
Thu, 05/7/15 - 11:22 am
Tags:
Big Pharma, Boehringer Ingelheim, Novartis, Pfizer, AstraZeneca, Sanofi
Is Novartis an Up-and-Coming Oncology Powerhouse?
Yahoo/Market Realist
Wed, 05/6/15 - 08:51 am
Tags:
Novartis, oncology, cancer
Novartis Looks Much Healthier
Barron's
Sat, 05/2/15 - 01:11 pm
Tags:
Novartis, oncology, GSK, Eli Lilly
Novartis faces more kickback scrutiny after $45M Express Scripts settlement
Fierce Pharma
Fri, 05/1/15 - 03:59 pm
Tags:
Novartis, kickbacks, Express Scripts
Novartis chief: We're actively looking for $2-$5 billion acquisitions
BioPharma Dive
Mon, 04/27/15 - 09:39 am
Tags:
Novartis, M&A, Joe Jimenez
What biopharma needs to know about CAR-T cancer therapies
BioPharma Dive
Sun, 04/26/15 - 09:21 am
Tags:
CAR-T, Novartis, CTL019
With GSK swap behind it, Novartis scouts for $2B-$5B buyouts
Fierce Biotech
Thu, 04/23/15 - 10:50 am
Tags:
GSK, Novartis, M&A
Novartis' 'megablockbuster' heart drug LCZ696 wins another rave preview
Fierce Biotech
Thu, 04/23/15 - 09:55 am
Tags:
LCZ696, Novartis
Novartis profit boosted by disposals
Marketwatch
Thu, 04/23/15 - 03:17 am
Tags:
Novartis, earnings
Novartis solid tumor 'CAR T cell' still holds promise - researcher
Yahoo/Reuters
Tue, 04/21/15 - 09:21 am
Tags:
Novartis, solid tumors, CAR-T
Juno stock drops on report of lackluster immunotherapy results on solid tumors
Bizjournals.com
Mon, 04/20/15 - 05:23 pm
Tags:
Juno Therapeutics, solid tumors, Novartis
Novartis' new CAR-T hopeful looks safe in an early solid tumor study
Fierce Biotech
Mon, 04/20/15 - 11:53 am
Tags:
Novartis, CAR-T, immuno-oncology
It's A Big Weekend For Biotech
Yahoo/Benzinga
Sat, 04/18/15 - 11:55 am
Tags:
biotech, Biogen, BIIB037, RG7800, PTC Therapeutics, Alnylam, CAR-T, Merck, Bristol-Myers Squibb, Novartis, Juno Therapeutics, Bellicum
Amgen motion to delay Neupogen biosimilar denied
Medical Marketing and Media
Fri, 04/17/15 - 08:44 am
Tags:
Amgen, Neupogen, biosimilars, Zarxio, Novartis, Sandoz
Novartis has fresh data to support newly acquired CCL drug Arzerra
Fierce Pharma
Wed, 04/15/15 - 10:30 am
Tags:
Novartis, Arzerra, chronic lymphocytic leukemia, GSK

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.